Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries,
especially in the elderly. Many risk factors have been identified for venous thrombosis that …

In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports
appeared describing venous thrombosis and pulmonary emboli in women using this method …

En Colombia la implementación de procesos de detección, prevención y disminu ción de
riesgos en salud y seguridad en el trabajo, es responsabilidad de los prestadores de …

Objective To assess the thrombotic risk associated with oral contraceptive use with a focus
on dose of oestrogen and type of progestogen of oral contraceptives available in the …

von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder
affecting both males and females, causing mucous membrane and skin bleeding symptoms …

Estrogen and progestins have been used by millions of women as effective combined oral
contraceptives. Oral contraceptives (OCs) modify surrogate markers such as lipoproteins …

Estrogen-containing medication, prescribed either for contraception in women of
reproductive age or for prevention of cardiovascular events and osteoporosis as well as for …

Venous thromboembolism is an episodic disease with an annual incidence of 2 to 3/1000
per year that is associated with a high morbidity and mortality. Risk factors for venous …

The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …

Over the last decade we have witnessed an avalanche of newly identified risk factors for
venous thrombosis. This has advanced our knowledge of its etiology, because more …